C

Curia

End-to-end drug development and manufacturing

Production Technician

Full-TimePosted on 10/8/2026
$28.60/hr
Entry
Bachelor's, Associate's
Rensselaer, NY, USA
In Person
Manufacturing & Production OperationsMachine & Process Operation

About the job

Requirements
  • Willingness to work the 6:30 PM–6:30 AM night shift.
  • Willingness to train on days or nights.
  • High school diploma or equivalent.
  • Ability to lift a maximum of 50 pounds.
  • Advanced math skills.
  • Ability to follow FDA manufacturing guidelines.
  • Communication skills.
Responsibilities
  • Complete required training, including building-specific safety, SOP review documentation, Production Technician core competency in the Learning Management System, and site safety and emergency notification and response procedures.
  • Learn and understand common chemical terminology, including reflux, distillation, azeotrope, separations, pH, milliliters, filtration, melting point, flash point, vapor pressure, density, boiling point, filter press, and filtrate.
  • Read, understand, and interpret Material Safety Data Sheets.
  • Understand and maintain plant documentation, including batch records, cleaning protocols, equipment use logs, equipment status tags, and labeling systems and label generation.
  • Learn proper weighing and scaling operations; review batch records; inspect equipment; drum and package material; understand purging; follow labeling procedures; read and understand sampling and analytical report forms; use, clean, and reset Niagara ceramic and Furan box filters; calibrate pH meters; set up and charge reactors; understand scrubber operation and recharging; practice proper grounding; control intermediates; accept raw materials; control finished products; use handheld terminals and bar-code systems; conduct pressure-filter operation; set up reactors for reflux, distillation, and azeotrope; use and understand pumps and TCMs; use manual jacket services for reactor heating and cooling; and document work proficiently.
  • Follow the dress code and personal protective equipment SOP.
  • Perform duties safely in accordance with the Rensselaer Safety Program, Good Manufacturing Practices for active pharmaceutical intermediates, and the Rensselaer Environmental Program.
  • Learn the building's process and recommend and implement methods to increase product and service quality.
  • Participate in self-development activities.
  • Perform other related duties reasonably assigned in the course of business.
Desired Qualifications
  • Knowledge and understanding of plant documentation, including batch records, cleaning protocols, equipment use logs, equipment status tags, and labeling systems and label generation.
  • Associate's or Bachelor's degree.
  • Prior chemical experience.

About the company

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.

INACTIVE